Caprolactam Chemicals Ltd Stock Price Today (NSE: CAPRO)
Fundamental Score
Caprolactam Chemicals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Caprolactam Chemicals Ltd share price today is ₹45.05, up +0.00% on NSE/BSE as of 30 March 2026. Caprolactam Chemicals Ltd (CAPRO) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of ₹29.10 (Cr). The 52-week high for CAPRO share price is ₹81.00 and the 52-week low is ₹37.53. At a P/E ratio of 2910.48x, CAPRO is currently trading above its industry average P/E of 20.98x. The company has a Return on Equity (ROE) of -13.68% and a debt-to-equity ratio of 1.70.
Caprolactam Chemicals Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Caprolactam Chemicals Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Caprolactam Chemicals Share Price: A Financial Stability Analysis
The commodity chemicals industry, often driven by cyclical demand and volatile raw material prices, presents unique challenges for financial stability. This analysis focuses on Caprolactam Chemicals share price, currently trading at ₹69.72. A cursory look at key metrics reveals potential areas of concern that warrant deeper investigation. The company's Price-to-Earnings (PE) ratio stands at an exceptionally high 2910.48, suggesting the share price may be significantly overvalued relative to current earnings. This, coupled with a negative Return on Capital Employed (ROCE) of -0.48%, signals a lack of profitability and efficient capital utilization.
The negative ROCE is particularly impactful. A healthy ROCE indicates a company's ability to generate profit from its capital investments, contributing to a wider economic moat. In contrast, Caprolactam Chemicals' negative ROCE suggests difficulties in creating a sustainable competitive advantage and generating returns for shareholders.
When compared to sector peers, the picture becomes clearer. While a detailed analysis of
AG Ventures requires a separate assessment, anecdotal evidence suggests differences in management quality can drastically impact operational efficiency and profitability. For example, publicly available information on AG Ventures indicates consistently positive, although perhaps modest, ROCE figures. This raises questions about Caprolactam Chemicals Ltd's internal processes and strategic decision-making relative to potentially more effectively managed competitors.Further investigation into Caprolactam Chemicals' financial statements is necessary to determine the underlying causes of the low ROCE. Factors such as high debt levels, inefficient production processes, or unfavorable market conditions could be contributing. Furthermore, analyzing cash flow generation, debt repayment capacity, and overall liquidity is crucial to ascertain the company's ability to weather potential economic downturns.
Disclaimer: This is an observational financial analysis of Caprolactam Chemicals share price based on publicly available data and does not constitute investment advice. This analysis is part of a comprehensive 80-parameter fundamental audit of the company's financial stability, verified by Sweta Mishra. Readers are advised to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Caprolactam Chemicals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CAPRO across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (31.20%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (225.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (38.01%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Balanced Promoter Holding (54.05%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-13.68%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.48%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 2910.48x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Limited Growth History (0.70% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Elevated Debt Levels (D/E: 1.70)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (1.19x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-4.30 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Caprolactam Chemicals Ltd Financial Statements
Comprehensive financial data for Caprolactam Chemicals Ltd including income statement, balance sheet and cash flow
About CAPRO (Caprolactam Chemicals Ltd)
Caprolactam Chemicals Ltd is a dynamic manufacturer and distributor entrenched within the Indian commodity chemical sector. Established in 1988 and headquartered in Mahad, India, C...APRO distinguishes itself through its focused production and distribution of specialized chemical compounds. The company’s core strength lies in its ability to deliver consistent quality and reliability to its customers, building lasting partnerships across diverse industrial applications. Operating with a lean and efficient organizational structure, CAPRO prioritizes responsiveness to market demands and agility in adapting its production processes. The company is driven by innovation and customer satisfaction, positioning itself as a preferred partner for businesses seeking reliable chemical solutions in India. CAPRO’s operations are not confined solely to manufacturing its own chemical products. A significant aspect of its business model includes providing specialized job work services, leveraging its production expertise and infrastructure to meet the bespoke requirements of other chemical companies. This service offering reflects CAPRO's commitment to optimizing resource utilization and expanding its reach within the chemical industry value chain. By offering comprehensive job work solutions, the company reinforces its position as a versatile and trusted partner, facilitating collaboration and efficiency across the sector. This diversification demonstrates CAPRO's ability to adapt and capitalize on opportunities beyond its primary product offerings. The company's journey began under a different identity, formerly known as Vamotiwala Chemicals Industries Limited, before rebranding to Caprolactam Chemicals Limited. This evolution underscores CAPRO’s strategic vision and its dedication to aligning its corporate identity with its core business focus. The name change reflects a pivotal moment in the company's history, signifying a shift toward specialized chemical production and a renewed commitment to excellence. The company continues to build upon its legacy, enhancing its capabilities to meet the evolving demands of the chemical market while maintaining its steadfast commitment to quality and customer satisfaction.
Company Details
Key Leadership
Corporate Events
Latest News
CAPRO Share Price: Frequently Asked Questions
What is the current share price of Caprolactam Chemicals Ltd (CAPRO)?
As of 30 Mar 2026, 12:01 pm IST, Caprolactam Chemicals Ltd share price is ₹45.05. The CAPRO stock has a market capitalisation of ₹29.10 (Cr) on NSE/BSE.
Is CAPRO share price Overvalued or Undervalued?
CAPRO share price is currently trading at a P/E ratio of 2910.48x, compared to the industry average of 20.98x. Based on this relative valuation, the Caprolactam Chemicals Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of CAPRO share price?
The 52-week high of CAPRO share price is ₹81.00 and the 52-week low is ₹37.53. These values are updated daily from NSE/BSE price data.
What factors affect the Caprolactam Chemicals Ltd share price?
Key factors influencing CAPRO share price include quarterly earnings growth (Sales Growth: 38.01%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Caprolactam Chemicals Ltd a good stock for long-term investment?
Caprolactam Chemicals Ltd shows a 5-year Profit Growth of N/A% and an ROE of -13.68%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.70 before investing in CAPRO shares.
How does Caprolactam Chemicals Ltd compare with its industry peers?
Caprolactam Chemicals Ltd competes with major peers in the Commodity Chemicals. Investors should compare CAPRO share price P/E of 2910.48x and ROE of -13.68% against the industry averages to determine competitive standing.
What is the P/E ratio of CAPRO and what does it mean?
CAPRO share price has a P/E ratio of 2910.48x compared to the industry average of 20.98x. Investors pay ₹2910 for every ₹1 of annual earnings.
How is CAPRO performing according to Bull Run's analysis?
CAPRO has a Bull Run fundamental score of 27.4/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does CAPRO belong to?
CAPRO operates in the Commodity Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Caprolactam Chemicals Ltd share price.
What is Return on Equity (ROE) and why is it important for CAPRO?
CAPRO has an ROE of -13.68%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Caprolactam Chemicals Ltd generates profits from shareholders capital.
How is CAPRO debt-to-equity ratio and what does it indicate?
CAPRO has a debt-to-equity ratio of 1.70, which indicates high leverage that increases financial risk.
What is CAPRO dividend yield and is it a good dividend stock?
CAPRO offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Caprolactam Chemicals Ltd shares.
How has CAPRO share price grown over the past 5 years?
CAPRO has achieved 5-year growth rates of: Sales Growth 0.70%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in CAPRO and why does it matter?
Promoters hold 54.05% of CAPRO shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Caprolactam Chemicals Ltd.
What is CAPRO market capitalisation category?
CAPRO has a market capitalisation of ₹29 crores, placing it in the Small-cap category.
How volatile is CAPRO stock?
CAPRO has a beta of N/A. A beta > 1 suggests the Caprolactam Chemicals Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is CAPRO operating profit margin trend?
CAPRO has a 5-year average Operating Profit Margin (OPM) of 31.20%, indicating the company's operational efficiency.
How is CAPRO quarterly performance?
Recent quarterly performance shows Caprolactam Chemicals Ltd YoY Sales Growth of 38.01% and YoY Profit Growth of 225.00%.
What is the institutional holding pattern in CAPRO?
CAPRO has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Caprolactam Chemicals Ltd stock.